In particular, three genes (PLAU, MMP-1, and LGALS3)—besides LCN2, whose role in aggressive thyroid cancer has been discussed above—are highly sensitive to NF-κB inhibition in BRAFV600E-mutated PTC cells [50]. Here, LCN2 is linked to thyroid cancer.